Metabolic Diseases

Solutions by Therapeutic Area

We provide a variety of preclinical research services to support the development of therapies targeting metabolic diseases. Utilizing optimized animal models for type II diabetes and obesity, we systematically evaluate the efficacy and safety of drugs.

If you need data for successful therapeutic development and global market entry, trust us to deliver the best solutions for your innovative research.

Metabolic Disease FAQs

What are the representative animal models used in metabolic disease research?

db/db Mouse Model: Used for type II diabetes research.
DIO Mouse Model: Suitable for diet-induced obesity studies.
High-Fat Diet Mouse Model: Used for obesity research induced by high-fat diets.

How long does efficacy evaluation for metabolic diseases take?

Typically, it takes 4 to 8 weeks. The timeline depends on the research goals, animal models, and experimental design. Detailed schedules are provided during the initial consultation.

Is analysis using DEXA equipment available?

Yes, we utilize DEXA (Dual-Energy X-ray Absorptiometry) to precisely analyze body fat percentage, bone density, and muscle mass. This data is crucial for research on obesity treatments and metabolic disease-related drugs.

Can you support studies requiring BSL-2 facilities?

Yes, we have BSL-2 certified facilities to accommodate research involving pathogenic agents or genetically modified mice.

Solutions by Therapeutic Area